VIRAL SAFETY ISSUES - PLASMA-DERIVED FACTOR-VIII

被引：2
|
作者：
BERNTORP, E
机构：
[1] Coagulation Laboratory, Malmö Allmänna Sjukhus, Malmö
来源：
ANNALS OF HEMATOLOGY | 1994年 / 68卷
关键词：
D O I：
10.1007/BF01774528
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：S35 / S36
页数：2
相关论文
共 50 条
  • [21] RECOMBINANT FACTOR-VIII (RECOMBINATE) - KEY ISSUES IN SAFETY AND EFFICACY
    GOMPERTS, ED
    TRANSFUSION, 1992, 32 (05) : 485 - 485
  • [22] Viral safety evaluation of plasma-derived therapeutic products
    Farshid, M
    PDA/EMEA EUROPEAN VIRUS SAFETY FORUM, 2004, 118 : 11 - 15
  • [23] FACTOR-VIII INHIBITOR ASSAYS USING PLASMA-DERIVED FVIII VERSUS RECOMBINANT FVIII - A COMPARATIVE-STUDY
    HILLMANWISEMAN, C
    VITALE, C
    LUSHER, J
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 684 - 684
  • [24] Plasma-derived versus recombinant factor VIII for the treatment of hemophilia A
    Kasper, CK
    VOX SANGUINIS, 1996, 70 : 17 - 20
  • [25] Cellular Stress Induced by Plasma-Derived Factor VIII Products
    Brodde, Martin
    Mueller, Anja
    Kehrel, Beate
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2014, 41 (02) : 140 - 144
  • [26] Biological and biochemical assays to ensure the quality and safety of plasma-derived products: Factor VIII concentrates
    Radosevich, Miryana
    Burnouf, Thierry
    CURRENT PHARMACEUTICAL ANALYSIS, 2007, 3 (02) : 83 - 94
  • [27] INCIDENCE OF FACTOR-VIII INHIBITOR DEVELOPMENT IN HEMOPHILIA-A PATIENTS TREATED WITH LESS PURE PLASMA-DERIVED CONCENTRATES
    DEBIASI, R
    ROCINO, A
    PAPA, ML
    SALERNO, E
    MASTRULLO, L
    DEBLASI, D
    THROMBOSIS AND HAEMOSTASIS, 1994, 71 (05) : 544 - 547
  • [28] Biological considerations of plasma-derived and recombinant factor VIII immunogenicity
    Lai, Jesse
    Hough, Christine
    Tarrant, Julie
    Lillicrap, David
    BLOOD, 2017, 129 (24) : 3147 - 3154
  • [29] Changing recombinant factor VIII to plasma-derived factor VIII during immune tolerance induction
    Dias, Maise Moreira
    Camelo, Ricardo Mesquita
    de Magalhaes, Laura Peixoto
    Jardim, Leticia Lemos
    de Oliveira, Andrea Goncalves
    de Albuquerque Ribeiro, Rosangela
    Franco, Vivian Karla Brognoli
    de Araujo Callado, Fabia Michelle Rodrigues
    Lorenzato, Claudia Santos
    Rezende, Suely Meireles
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2024, 41 (01) : 74 - 80
  • [30] RECOMBINANT AND PLASMA-DERIVED FACTOR-VIIA DO NOT CORRECT BLEEDING-TIME IN A RABBIT FACTOR-VIII INHIBITOR MODEL
    TURECEK, PL
    SCHWARZ, HP
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 986 - 986
12345